Metastatic Nasopharyngeal Carcinoma Clinical Trials in Zhuhai, Guangdong
3 recruitingZhuhai, Guangdong, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal Carcinoma
Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen33 enrolled1 locationNCT07581821
Recruiting
Phase 2
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen208 enrolled6 locationsNCT07070479
Recruiting
Phase 2
Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC
Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen32 enrolled1 locationNCT06472713